A New Possible Way to Evaluate Bioequivalence of Topical Drugs U.S. Food and Drug Administration 0:54 5 years ago 2 714 Далее Скачать
In Vitro Bioequivalence Studies of Topical Drug Products: Challenges and Promises of IVRT and IVPT U.S. Food and Drug Administration 20:45 3 years ago 3 646 Далее Скачать
Topical Dosage Forms: Emerging Insights and Implications for Bioequivalence Approaches U.S. Food and Drug Administration 20:11 3 years ago 1 207 Далее Скачать
Developing and Implementing Science-Based Standards in Bioequivalence Assessment U.S. Food and Drug Administration 21:11 3 years ago 759 Далее Скачать
How Regulatory Science Benefits Patients U.S. Food and Drug Administration 2:30 7 years ago 1 472 Далее Скачать
Assessment of Complex Drug Product – Physicochemical Characteristics to Support In Vitro BE Studies U.S. Food and Drug Administration 19:32 3 years ago 1 516 Далее Скачать
Pharmacokinetics - Part 1: Topical and Systemic Drugs AMBOSS: Medical Knowledge Distilled 6:28 5 years ago 54 478 Далее Скачать
In Vitro Bioequivalence Testing of Topical Generic Products Teledyne Hanson Research 55:11 4 years ago 2 120 Далее Скачать
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs Certara 58:30 4 years ago 1 445 Далее Скачать
Blinding of Bioequivalence Trials (9of11) GCP Data Integrity U.S. Food and Drug Administration 18:22 4 years ago 2 402 Далее Скачать
In Vitro Release Testing for Complex Generics: A Bioequivalence Perspective U.S. Food and Drug Administration 21:09 3 years ago 2 497 Далее Скачать
Quantitative Methods for Determining Equivalence of Particle Size Distributions U.S. Food and Drug Administration 18:34 3 years ago 1 730 Далее Скачать
Bioequivalence for Generic Topical and Transdermal (6of35) Complex Generics– Sep. 25-26, 2019 U.S. Food and Drug Administration 23:51 4 years ago 1 195 Далее Скачать
Practical Considerations for Bioequivalence of GI Locally-Acting Products U.S. Food and Drug Administration 20:33 3 years ago 675 Далее Скачать
Complex Generics: Topical Products, Part 1 U.S. Food and Drug Administration 1:57:52 3 years ago 2 165 Далее Скачать
Best Practices for Topical Generic Product Development & ANDA Submission–Session 3, Closing Remarks U.S. Food and Drug Administration 58:05 2 years ago 696 Далее Скачать
Bioavailability/Bioequivalence Site Evaluation During the Pandemic U.S. Food and Drug Administration 17:43 3 years ago 528 Далее Скачать
Case Studies: Inadequate Bioequivalence Studies (18of28) Generic Drugs Forum – Apr. 3-4, 2019 U.S. Food and Drug Administration 23:31 4 years ago 705 Далее Скачать
In vitro bioequivalence testing for topical ophthalmic suspension products (17of39) Complex Generics U.S. Food and Drug Administration 19:46 4 years ago 3 454 Далее Скачать